ISSN: 0390-6078

Journal Home

Haematologica Q1 Unclaimed

Ferrata Storti Foundation Italy

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Haematologica is a journal indexed in SJR in Hematology with an H index of 155. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 1600 €. The scope of the journal is focused on hematology, oncology. It has an SJR impact factor of 2,557 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,557.

Haematologica focuses its scope in these topics and keywords: cell, disease, multiple, gene, leukemia, myeloid, myeloma, lymphoma, marrow, minimal, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1)

Price

1600 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,557

SJR Impact factor

155

H Index

391

Total Docs (Last Year)

1397

Total Docs (3 years)

11389

Total Refs

6950

Total Cites (3 years)

877

Citable Docs (3 years)

5.12

Cites/Doc (2 years)

29.13

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Journal of Hematology and Oncology Q1
Blood Q1
The Lancet Haematology Q1
Blood Cancer Journal Q1

Compare this journals

Aims and Scope

Best articles by citations

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia

EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma

DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies

Cytokines in combination to treat radiation-induced myelosuppresssion: evaluation of SCF + glycosylated EPO + pegylated G-CSF as an emergency treatment in highly irradiated monkeys

Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?

Mutations in the telomere capping complex in bone marrow failure and related syndromes

Co-expression of the collagen receptors leukocyte-associated immunoglobulin-like receptor-1 and glycoprotein VI on a subset of megakaryoblasts

SHOW MORE ARTICLES

The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints

Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation

Treatment of acute myeloid leukemia

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma

Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis

Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center

Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia

Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia

Hemophilia A: different phenotypes may be explained by multiple and variable effects of the causative mutation in the

Identification of minor histocompatibility antigens based on the 1000 Genomes Project